Invention Grant
- Patent Title: Hydrosoluble compounds derived from benzimidazole used in treating fasciolosis
-
Application No.: US15529218Application Date: 2015-11-25
-
Publication No.: US10239842B2Publication Date: 2019-03-26
- Inventor: Rafael Castillo Bocanegra , Miguel Angel Flores Ramos , Maria Alicia Hernandez Campos , Osvaldo Froylan Ibarra Velarde , Remedios Yolanda Vera Montenegro
- Applicant: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
- Applicant Address: MX Mexico City
- Assignee: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
- Current Assignee: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
- Current Assignee Address: MX Mexico City
- Agency: Shumaker, Loop & Kendrick, LLP
- Priority: MXMX/a/2014/014417 20141126
- International Application: PCT/MX2015/000154 WO 20151125
- International Announcement: WO2016/085319 WO 20160602
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/4184 ; C07D235/28 ; C07F9/09 ; A61K31/66 ; C07F9/6506

Abstract:
The present invention relates to hydrosoluble compounds derived from benzimidazole represented by general formula I: wherein: Y1 e Y2 are independently O or S, and at least one of Y1 and Y2 is O; R1 and R2 are independently hydrogen or a cation, both are hydrogen or both are cations; R3 is a C1-4 alkyl; R4 and R5 are independently halogen or a —OR6 alkoxide; R6 is C6-C10 aryl linked in 5- or 6-position of benzimidazole nucleus.
Public/Granted literature
- US20170327470A1 NOVEL HYDROSOLUBLE COMPOUNDS DERIVED FROM BENZIMIDAZOLE USED IN TREATING FASCIOLOSIS Public/Granted day:2017-11-16
Information query